|
Tender for Bid Document For Rate Contract For Supply Of Restricted Medicines For A Period Of Two Years , Abemaciclib 50 Mg , Abemaciclib 100 Mg , Abemaciclib 150 Mg , Abemaciclib 200 Mg , Aldurazyme 0.58 Mg/Kg , Alectinib 150 Mg , Alglucosidase Alfa 50 Mg/Vial , Alpelisib 150 Mg , Alpelisib 200 Mg , Alpelisib 250 Mg , Amivantamab 350 Mg , Asciminib 40 Mg , Atezolizumab 1875 Mg/ 15 Ml , Atezolizumab 1200 Mg/20 Ml , Avelumab 200 Mg , Baricitinib 2Mg , Baricitinib 4Mg , Baricitinib 1Mg , Belantamab Mafodotin 70Mg/Vial And , Belantamab Mafodotin 100Mg/Vial , Belumosudil 200 Mg , Benralizumab 30 Mg , Brentuximab Vedotin 50 Mg , Brolucizumab 120 Mg/Ml , Capmatinib 150 Mg , Capmatinib 200 Mg , Ceritinib 150Mg , Concizumab 60 Mg , Concizumab 150 Mg , Dabrafenib 75 Mg , Daratumumab 100 Mg , Daratumumab 400 Mg , Daratumumab 1800 Mg , Darolutamide 300 Mg , Datopotamab Deruxtecan 100Mg , Dexamethasone Intravitreal Implant 0.7 Mg , Dinutuximab 200Mg/2Ml , Donanemab 350Mg/20Ml (17.5Mg/Ml) , Dostarlimab 500 Mg/10 Ml , Durvalumab 120 Mg , Durvalumab 500 Mg , Eculizumab 300 Mg/30 Ml , Elranatamab Solution For Injection(R-Dna Origin) 44 Mg/1.1 Ml(40Mg/Ml) , Elranatamab Solution For Injection(R-Dna Origin) 76 Mg/1.9 Ml(40Mg/Ml) , Emicizumab 30 Mg/Ml , Emicizumab 60 Mg/0.4 Ml , Emicizumab 105 Mg/0.7 Ml , Emicizumab 150 Mg/1 Ml , Enfortumab Vedotin 20 Mg , Enfortumab Vedotin 30 Mg , Entrectinib 100 Mg , Entrectinib 200 Mg , Eptacog Alfa (Activated) 1 Mg , Eptacog Alfa (Activated) 2 Mg , Erenumab 70 Mg/Ml , Evolocumab 140 Mg , Faricimab 6 Mg/0.05 Ml , Gilteritinib 40 Mg , Goserelin Acetate 3.6Mg , Goserelin Acetate 10.8Mg , Guselkumab 100 Mg , Imiglucerase 400 Iu , Inclisiran 284 Mg/1.5 Ml , Inotuzumab Ozogamicin 1 Mg , Ipilimumab 50 Mg , Ivosidenib 250 Mg , Ixekizumab 80 Mg , Lecanemab 200Mg/2Ml , Letermovir 240 Mg , Letermovir 480 Mg , Lorlatinib 25 Mg , Lorlatinib 100 Mg , Luspatercept 25 Mg , Luspatercept 75 Mg , Mavacamten 2.5 Mg , Mavacamten 5 Mg , Mavacamten 10 Mg , Mavacamten 15 Mg , Mepolizumab 100 Mg , Methoxy Peg-Epoetin Beta 50 Mcg , Methoxy Peg-Epoetin Beta 75 Mcg , Methoxy Peg-Epoetin Beta 100 Mcg , Nimotuzumab 50 Mg , Niraparib 100 Mg , Nivolumab And Relatlimab 240Mg/80Mg , Nonacog Beta Pegol 500 Iu , Nonacog Beta Pegol 1000 Iu , Nonacog Beta Pegol 2000 Iu , Obinutuzumab 1000 Mg , Ocrelizumab 300 Mg , Osimertinib 80Mg , Pacritinib 100Mg , Panitumumab 100 Mg , Pegylated Liposomal Irinotecan 4.3 Mg/Ml , Pembrolizumab 100 Mg , Polatuzumab Vedotin 30 Mg , Ramucirumab 100 Mg/10 Ml , Ramucirumab 500 Mg/50 Ml , Ribociclib 200Mg/2Ml , Rimegepant 75 Mg , Romosozumab 105 Mg/1.17 Ml , Ruxolitinib 5Mg , Ruxolitinib 15Mg , Ruxolitinib 20Mg , Selpercatinib 40 Mg , Selpercatinib 80 Mg , Selpercatinib 120 Mg , Selpercatinib 160 Mg , Serplulimab 100 Mg/10 Ml , Sodium Zirconium Cyclosilicate 5 Gm , Somatrogon 24 Mg , Somatrogon 60 Mg , Sotatercept 45 Mg , Sotatercept 60 Mg , Talquetamab 3 Mg , Talquetamab 40Mg , Teclistamab 30 Mg , Teclistamab 153 Mg , Tepotinib 225 Mg , Tildrakizumab 100Mg/Ml , Tirzepatide 2.5 Mg , Tirzepatide 5 Mg , Tirzepatide 7.5 Mg , Tirzepatide 10 Mg , Tirzepatide 12.5 Mg , Tirzepatide 15 Mg , Tislelizumab 100 Mg , Toripalimab 240 Mg/6 Ml , Trametinib 0.5 Mg , Trastuzumab Deruxtecan 100 Mg , Tremelimumab 300 Mg/15 Ml , Turoctocog Alfa Pegol 500 Iu , Turoctocog Alfa Pegol 1000 Iu , Turoctocog Alfa Pegol 1500 Iu , Turoctocog Alfa Pegol 2000 Iu , Vedolizumab 300 Mg , Venetoclax 100 Mg , Vorasidenib 10 Mg , Vorasidenib 40 Mg , Zanubrutinib 80 Mg , Zolbetuximab 100Mg , Zolbetuximab 300Mg
|
